C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.46
0.11 (4.68%)
At close: Aug 15, 2025, 3:59 PM
2.46
0.20%
After-hours: Aug 15, 2025, 06:51 PM EDT
C4 Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 27.78M | 39.78M | 35.58M | 33.67M | 29.38M | 20.04M | 20.76M | 20.35M | 16.03M | 27.2M | 31.1M | 48.32M | 50.07M | 46.01M | 45.78M | 33.97M | 33.92M |
Cost of Revenue | 3.82M | 5.87M | 7.89M | 7.82M | 7.76M | 7.7M | 7.74M | 8.07M | 7.99M | 8.14M | 7.57M | 6.31M | 28.69M | 49.84M | 68.87M | 87.58M | 87.21M |
Gross Profit | 23.95M | 33.92M | 27.69M | 25.85M | 21.62M | 12.33M | 13.02M | 12.28M | 8.04M | 19.06M | 23.52M | 42.01M | 21.38M | -3.82M | -23.09M | -53.61M | -53.29M |
Operating Income | -123.62M | -116.56M | -119.61M | -119.33M | -118.9M | -135.02M | -139.03M | -139.9M | -144.58M | -134.39M | -129.53M | -106.5M | -98.26M | -92.99M | -82.13M | -85.78M | -79.88M |
Interest Income | 9.69M | 13.41M | 14.43M | 14.11M | 13.1M | 11.62M | 9.81M | 8.57M | 7.09M | 5.35M | 3.58M | 2M | 1.03M | 591K | 387K | 827K | 767K |
Pretax Income | -111.45M | -103.15M | -105.19M | -105.22M | -106.59M | -124.79M | -131.21M | -133.92M | -139.84M | -131.34M | -128.18M | -106.65M | -99.37M | -94.54M | -83.89M | -90.15M | -87.47M |
Net Income | -111.58M | -103.28M | -105.32M | -105.5M | -107.87M | -126.07M | -131.65M | -132.97M | -137.37M | -128.88M | -126.82M | -106.4M | -99.65M | -94.79M | -83.89M | -90.03M | -87.18M |
Selling & General & Admin | 40.24M | 41.17M | 42.12M | 40.36M | 39.12M | 39.73M | 40.39M | 42.28M | 41.33M | 40.91M | 42.79M | 41.08M | 39.95M | 38.66M | 33.25M | 31.2M | 25.61M |
Research & Development | 117.62M | 115.18M | 110.64M | 108.52M | 105.02M | 111.2M | 117.71M | 117.97M | 119.28M | 120.68M | 117.84M | 113.74M | 108.38M | 100.34M | 94.67M | 88.55M | 88.18M |
Other Expenses | n/a | n/a | 2.44M | 2.44M | 2.44M | 2.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 43K |
Operating Expenses | 156.09M | 154.58M | 153.43M | 151.31M | 146.58M | 153.37M | 158.1M | 160.25M | 160.61M | 161.59M | 160.63M | 154.82M | 148.33M | 139.01M | 127.92M | 119.75M | 113.79M |
Interest Expense | n/a | n/a | n/a | n/a | 167K | 767K | 1.37M | 1.97M | 2.36M | 2.29M | 2.22M | 2.15M | 2.14M | 2.14M | 2.15M | 2.67M | 2.69M |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.69M | -1.69M | -1.69M | -1.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 122.89M | 156.34M | 155.2M | 153M | 148.27M | 155.06M | 159.79M | 160.25M | 160.61M | 161.59M | 160.63M | 154.82M | 148.33M | 139.01M | 127.92M | 119.75M | 113.79M |
Income Tax Expense | 131K | 131K | -1.9M | -1.75M | -2.75M | -2.75M | -1.57M | -2.95M | -2.48M | -2.45M | -1.36M | -251K | 389K | 430K | 251K | 127K | -150K |
Shares Outstanding (Basic) | 71.01M | 70.83M | 70.61M | 69.63M | 68.81M | 68.43M | 51.22M | 49.21M | 49.06M | 49.03M | 48.97M | 48.92M | 48.82M | 48.65M | 48.49M | 48.49M | 43.86M |
Shares Outstanding (Diluted) | 71.01M | 70.83M | 70.61M | 69.63M | 68.81M | 68.43M | 51.22M | 49.21M | 49.06M | 49.03M | 48.97M | 48.92M | 48.82M | 48.73M | 48.49M | 48.49M | 43.86M |
EPS (Basic) | -1.58 | -1.47 | -1.51 | -1.7 | -1.9 | -2.37 | -2.65 | -2.71 | -2.8 | -2.63 | -2.6 | -2.18 | -2.05 | -2 | -1.83 | -2.04 | -2.07 |
EPS (Diluted) | -1.58 | -1.47 | -1.51 | -1.7 | -1.9 | -2.37 | -2.65 | -2.71 | -2.8 | -2.63 | -2.59 | -2.17 | -2.04 | -1.99 | -1.83 | -2.04 | -2.07 |
EBITDA | -112.5M | -99.67M | -97.29M | -97.4M | -98.66M | -116.33M | -122.1M | -123.88M | -129.49M | -120.89M | -118.39M | -98.19M | -92.52M | -89.11M | -79.17M | -85.22M | -82.13M |
EBIT | -88.27M | -105.99M | -105.19M | -105.22M | -106.42M | -124.03M | -129.84M | -131.95M | -137.48M | -129.04M | -125.96M | -104.49M | -97.23M | -92.4M | -81.75M | -87.49M | -84.78M |
Depreciation & Amortization | 4.28M | 6.32M | 7.89M | 7.82M | 7.76M | 7.7M | 7.74M | 8.07M | 7.99M | 8.14M | 7.57M | 6.31M | 5.05M | 3.63M | 2.91M | 2.51M | 2.27M |